Abbott Laboratories

Quarterly Financials

Values in thousands2026-03-312025-12-312025-09-302025-06-30
Revenue
$11,164,000
$11,459,000
$11,369,000
$11,142,000
Gross Profit
6,283,000
6,537,000
6,338,000
6,288,000
EBITDA
1,842,000
2,822,000
3,092,000
3,048,000
EBIT
2,400,000
2,301,000
2,271,000
Net Income
1,077,000
1,776,000
1,644,000
1,779,000
Net Change In Cash
11,164,000
11,459,000
11,369,000
11,142,000
Free Cash Flow
916,000
2,626,000
2,291,000
1,545,000
Cash
6,803,000
8,522,000
7,511,000
6,951,000
Basic Shares
1,747,000
1,747,000
1,749,000
1,751,000

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$44,328,000
$41,950,000
$40,109,000
$43,653,000
Gross Profit
24,607,000
21,325,000
20,037,000
22,323,000
EBITDA
11,553,000
10,834,000
10,605,000
11,888,000
EBIT
8,807,000
7,616,000
7,362,000
8,621,000
Net Income
6,524,000
13,402,000
5,723,000
6,933,000
Net Change In Cash
44,328,000
41,950,000
40,109,000
43,653,000
Cost of Revenue
205,000
Free Cash Flow
7,395,000
6,351,000
5,059,000
7,804,000
Cash
8,522,000
7,616,000
6,896,000
9,882,000
Basic Shares
1,747,000
1,748,000
1,749,000
1,764,000

Earnings Calls

QuarterEPS
2026-03-31
$1.15
2025-12-31
$1.50
2025-09-30
$1.30
2025-06-30
$1.01